| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6193236 | Journal of Thoracic Oncology | 2015 | 5 Pages |
Abstract
Among the EGFR wild-type population, when analyzed separately, high polysomy of chromosome 7 was the only molecular feature conferring clear signs of sensitivity to erlotinib. Therefore, the evaluation of high polysomy of chromosome 7 could become a helpful tool to predict for the benefit from epidermal growth factors tyrosine kinase inhibitors in selected cases.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Francesca MD, PhD, Filippo MD, Fabio MD, Gianluca MD, Chiara MD, Cristina MD, Chiara MD, Fabio MSc, Viviana PhD, Massimo MD, Tommaso MD,